Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Albendazole -Ivermectin Combination Treatment on Wuchereria Bancrofti Infection and Transmission in Mali

NCT02784743 is registered in ClinicalTrials.gov with Centre d'Appui à la lutte contre la Maladie as lead sponsor.

NCT NCT02784743
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02784743 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Albendazole -Ivermectin Combination Treatment on Wuchereria Bancrofti Infection and Transmission in Mali
Lead sponsor
Centre d'Appui à la lutte contre la Maladie
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2001
Completion date
April 30, 2015
Enrollment
1,139 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

lymphatic filariasis